Peter M. Venner

Edmonton, AB T6C4G9, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.

Journal: BMC genomic data

Published: January 15, 2026

High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experience.

High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experience.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: November 27, 2023

Cohort profile: the Alberta Prostate Cancer Research Initiative (APCaRI) Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, Canada.

Cohort profile: the Alberta Prostate Cancer Research Initiative (APCaRI) Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, Canada.

Journal: BMJ open

Published: October 17, 2020

Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting.

Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting.

Journal: The Canadian journal of urology

Published: December 21, 2019

The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.

The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 29, 2018

Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.

Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: February 01, 2018

First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience.

First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: May 19, 2017

High fat mass associates with occurrence of targeted therapy-induced left ventricular ejection fraction reduction in patients with renal cell carcinoma.

High fat mass associates with occurrence of targeted therapy-induced left ventricular ejection fraction reduction in patients with renal cell carcinoma.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: November 08, 2016

Avascular Necrosis of the Femoral Head After Palliative Radiotherapy in Metastatic Prostate Cancer: Absence of a Dose Threshold?

Avascular Necrosis of the Femoral Head After Palliative Radiotherapy in Metastatic Prostate Cancer: Absence of a Dose Threshold?

Journal: Cureus

Published: April 16, 2016

Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.

Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: July 31, 2015

A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors.

A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors.

Journal: Investigational new drugs

Published: January 19, 2015

Enzalutamide in metastatic prostate cancer before chemotherapy.

Enzalutamide in metastatic prostate cancer before chemotherapy.

Journal: The New England journal of medicine

Published: June 03, 2014

Showing 1-12 of 20

Last Updated: 09/26/2026